Weight Loss Jab Slashes Heart Attack Risk by 20%
A groundbreaking UK study reveals the diabetes drug Mounjaro (tirzepatide) isn't just for weight loss—it dramatically cuts the risk of heart attacks and strokes, heralding a new era in preventative medicine.